ALN-6400
The purpose of this study is to:
evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-6400 in healthy volunteers
evaluate the efficacy, safety, tolerability and PD of multiple doses of…
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Decipher
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
GB002-3102
This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All